Physiological role of aldosterone in pregnancy, importance of correction in pathological conditions. What is known about pharmacological targets
https://doi.org/10.18705/2311-4495-2021-8-4-35-46
Abstract
Aldosterone is the main mineralocorticosteroid hormone of the human adrenal cortex. It plays a key role in the regulation of kidney and cardiovascular function. Its role especially increases in the adaptation of the woman’s body during pregnancy, and consists in maintaining the balance of electrolytes, blood pressure, ensuring sufficient trophoblast invasion and adequate placental perfusion. This article describes the mechanism of synthesis and action of aldosterone, its biological role and place in the structure of the renin-angiotensin-aldosterone system (RAAS). A special place is given to aldosterone in maintaining hemodynamics during physiological pregnancy, and to violations of the RAAS, as a key to understanding the links in the pathogenesis of preeclampsia.
About the Authors
V. A. Karabeshkina
Almazov National Medical Research Centre
Russian Federation
Competing Interests:
Russian Federation
Karabeshkina Valeria A., Clinical Resident of the Department of Obstetrics and Gynecology of the Institute of Medical Education
Akkuratova str. 2, Saint Petersburg, Russia, 197341
Competing Interests:
The authors declare no conflict of interest
V. V. Ishkaraeva
Almazov National Medical Research Centre
Russian Federation
Competing Interests:
Russian Federation
Ishkaraeva Valentina V., PhD, Obstetrician-Gynecologist, Assistant of the Department of Obstetrics and Gynecology of the Institute of Medical Education
Akkuratova str. 2, Saint Petersburg, Russia, 197341
Competing Interests:
The authors declare no conflict of interest
I. E. Zazerskaya
Almazov National Medical Research Centre
Russian Federation
Competing Interests:
Russian Federation
Zazerskaya Irina E., Dr. Sc., Head of the Department of Obstetrics and Gynecology of the Institute of Medical Education
Almazov National Medical Research Centre
Competing Interests:
The authors declare no conflict of interest
References
1. Орлов Р.С., Ноздрачев А.Д. Нормальная физиология. М.: ГЭОТАР-Медиа, 2010. с. 832.
2. Делягин В.М., Румянцев А.Г. Артериальная гипертензия у детей и подростков. М.: ГЭОТАР-Медиа, 2021. с. 256.
3. Сухих Г. Т., Мурашко Л. Е., Ванько Л. В. и др. Преэклампсия. М.: ГЭОТАР-Медиа, 2010. с. 576.
4. Verdonk K, Visser W, Van Den Meiracker AH, et al. The renin-angiotensin-aldosterone system in preeclampsia: the delicate balance between good and bad. Clin Sci (Lond). 2014;126(8):537–544. DOI: 10.1042/CS20130455.
5. Singh AK, Williams GH. Textbook of Nephro-Endocrinology. Academic Press, 2008. p. 522.
6. Gekle M, Grossmann C. Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? Pflugers Arch. 2009;458(2):231–246. DOI: 10.1007/s00424-008-0616-0.
7. Marney AM, Brown NJ. Aldosterone and endorgan damage. Clin Sci (Lond). 2007;113(6):267–278. DOI: 10.1042/CS20070123.
8. Blasi ER, Rocha R, Rudolph AE, et al. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003;63(5):1791–1800. DOI: 10.1046/j.1523-1755.2003.00929.x.
9. Rossi GP, Bernini G, Desideri G, et al. Renal damage in primary aldosteronism: results of the PAPY study. Hypertension. 2006;48(2): 232–238. DOI: 10.1161/01.HYP.0000230444.01215.6a
10. Lumbers ER, Pringle KG. Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol. 2014;306(2):91–101. DOI: 10.1152/ajpregu.00034.2013.
11. Kurlak LO, Pipkin FB, Mohaupt MG, et al. Responses of the renin-angiotensin-aldosterone system in pregnant chronic kidney disease patients with and without superimposed pre-eclampsia. Clin Kidney J. 2019;12(6):847–854. DOI: 10.1093/ckj/sfz025.
12. Zitouni H, Raguema N, Gannoun MBA, et al. Impact of obesity on the association of active renin and plasma aldosterone concentrations, and aldosterone-torenin ratio with preeclampsia. Pregnancy Hypertens. 2018;14:139–144. DOI: 10.1016/j.preghy.2018.09.007
13. Сидельникова В.М. Эндокринология беременности в норме и при патологии. М.: МЕДпресс-информ, 2007. с. 351.
14. Ledoux F, Genest J, Nowaczynski W, et al. Plasma progesterone and aldosterone in pregnancy. Can Med Assoc J. 1975;112(8):943–947.
15. Wiegel RE, von Versen-Höynck F, Steegers- Theunissen RPM, et al. Prorenin periconceptionally and in pregnancy: Does it have a physiological role? Mol Cell Endocrinol. 2021;522:111–118. DOI: 10.1016/j.mce.2020.111118.
16. Кириллова Е.Н., Савочкина Ю.В., Коршикова Р.Л., Савицкая В.М.. Прогестерон и его роль в профилактике репродуктивных потерь. Медицина. 2013;3:43.
17. Smith MC, Danielson LA, Conrad KP, et al. Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers. J Am Soc Nephrol. 2006;17(11):3192–3197. DOI: 10.1681/ASN.2005090950.
18. Eisele N, Albrecht C, Mistry HD, et al. Placental expression of the angiogenic placental growth factor is stimulated by both aldosterone and simulated starvation. Placenta. 2016;40:18–24. DOI: 10.1016/j.placenta.2016.02.004.
19. Gennari-Moser C, Khankin EV, Schüller S, et al. Regulation of placental growth by aldosterone and cortisol. Endocrinology. 2011;152(1):263–271. DOI: 10.1210/en.2010-0525.
20. Todkar A, Di Chiara M, Loffing-Cueni D, et al. Aldosterone deficiency adversely affects pregnancy outcome in mice. Pflugers Arch. 2012;464(4):331–343. DOI: 10.1007/s00424-012-1145-4.
21. Gennari-Moser C, Escher G, Kramer S, et al. Normotensive blood pressure in pregnancy: the role of salt and aldosterone. Hypertension. 2014;63(2):362–368. DOI: 10.1161/HYPERTENSIONAHA.113.02320.
22. Gennari-Moser C, Khankin EV, Schüller S, et al. Regulation of placental growth by aldosterone and cortisol. Endocrinology. 2011;152(1):263–271. DOI: 10.1210/en.2010-0525.
23. Birukov A, Andersen LB, Herse F, et al. Aldosterone, salt, and potassium intakes as predictors of pregnancy outcome, including preeclampsia. Hypertension. 2019;74(2):391–398. DOI: 10.1161/HYPERTENSIONAHA.119.12924.
24. Мравян С.Р., Петрухин В.А. Электролитные нарушения и гиперальдостеронизм беременных как проявления возможного синдрома псевдо-Барттера. РМЖ. 2016; 5:340–344.
25. Макаров И.О., Шеманаева Т.В. Плацентарная недостаточность и протективная роль магния. Гинекология. 2012;14(2):28-31.
26. Болдырев А.А. Роль Na/K-насоса в возбудимых тканях. Журнал СФУ. Биология. 2008;1(3):206-225.
27. Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised place-bo-controlled trial. Lancet. 2002;359(9321):1877–1890. DOI: 10.1016/s0140-6736(02)08778-0.
28. Верткин А.Л. Роль магния и калия в комплексной терапии коморбидного больного. Лечащий врач. 2014;7:82-86.
29. Skou JC, Butler KW, Hansen O. The effect of magnesium, ATP, P i, and sodium on the inhibition of the (Na + + K +)-activated enzyme system by g-strophanthin. Biochim Biophys Acta. 1971;241(2):443–461. DOI: 10.1016/0005-2736(71)90044-7.
30. Zazerskaya IE, Ishkaraeva VV, Frolova EV, et al. Magnesium sulfate potentiates effect of digifab on marinobufagenin-induced Na/K-ATPase Inhibition. Am J Hypertens. 2013;26(11):1269–1272. DOI: 10.1093/ajh/hpt117.
Review
For citations:
Karabeshkina V.A., Ishkaraeva V.V., Zazerskaya I.E. Physiological role of aldosterone in pregnancy, importance of correction in pathological conditions. What is known about pharmacological targets. Translational Medicine. 2021;8(4):35-46. (In Russ.) https://doi.org/10.18705/2311-4495-2021-8-4-35-46
Views:
1641
Email this article 